Abstract:The gut microbiome is linked to brain pathology in cases of traumatic brain injury (TBI), yet the specific bacteria that are implicated are not well characterized. To address this gap, in this study, we induced traumatic brain injury (TBI) in male C57BL/6J mice using the controlled cortical impact (CCI) injury model. After 35 days, we administered a broad-spectrum antibiotics (ABX) cocktail (ampicillin, gentamicin, metronidazole, vancomycin) through oral gavage for 2 days to diminish existing microbiota. Subsequently, we inflicted a second TBI on the mice and analyzed the neuropathological outcomes five days later. Longitudinal analysis of the microbiome showed significant shifts in the diversity and abundance of bacterial genera during both acute and chronic inflammation. These changes were particularly dramatic following treatment with ABX and after the second TBI. ABX treatment did not affect the production of short-chain fatty acids (SCFA) but did alter intestinal morphology, characterized by reduced villus width and a lower count of goblet cells, suggesting potential negative impacts on intestinal integrity. Nevertheless, diminishing the intestinal microbiome reduced cortical damage, apoptotic cell density, and microglial/macrophage activation in the cortical and thalamic regions of the brain. Our findings suggest that eliminating colonized gut bacteria via broad-spectrum ABX reduces neuroinflammation and enhances neurological outcomes in TBI despite implications to gut health.

What problem does this paper attempt to address?

The problem this paper attempts to address is: exploring the impact of broad-spectrum antibiotics (ABX) on the gut microbiota of mice with traumatic brain injury (TBI) and its relationship with neuroinflammation. Specifically, the researchers aim to reduce the gut microbiota using broad-spectrum antibiotics to observe its effects on neuroinflammation and neuropathological outcomes post-TBI. ### Background and Research Objectives - **Background**: Traumatic brain injury (TBI) is a common cause of disability and death, often resulting from contact sports, military activities, or traffic accidents. TBI can be divided into acute and chronic phases, each with unique consequences and inflammatory responses that affect secondary inflammatory cascades and recovery in patients. - **Research Objectives**: The researchers aim to induce TBI and treat mice with broad-spectrum antibiotics at different time points to observe changes in the gut microbiota and how these changes affect neuroinflammation and neuropathological outcomes post-TBI. ### Research Methods - **Experimental Design**: - Induce the first TBI in male C57BL/6J mice using a controlled cortical impact (CCI) model. - After 35 days, administer a broad-spectrum antibiotic mixture (including ampicillin, gentamicin, metronidazole, and vancomycin) orally for 2 days to reduce the existing microbiota. - Subsequently, induce a second TBI and analyze neuropathological outcomes 5 days later. - **Detection Methods**: - Analyze the composition of the microbiota in fecal samples through 16S rRNA sequencing. - Evaluate neuropathological changes in the cortical and thalamic regions through histological staining and immunohistochemistry, including apoptosis density and microglia/macrophage activation. - Assess the motor function of mice using the rotarod test. ### Main Findings - **Microbiota Changes**: Broad-spectrum antibiotic treatment significantly altered the diversity and abundance of the gut microbiota, especially during acute and chronic inflammation phases. - **Neuroinflammation and Neuropathological Outcomes**: Although broad-spectrum antibiotic treatment did not affect the production of short-chain fatty acids (SCFA), it reduced villus width and goblet cell numbers in the gut, suggesting potential negative impacts on gut integrity. However, reducing the gut microbiota significantly decreased cortical damage, apoptosis density, and microglia/macrophage activation in the cortical and thalamic regions. - **Conclusion**: The findings suggest that eliminating gut-colonizing bacteria with broad-spectrum antibiotics can reduce neuroinflammation and improve neuropathological outcomes post-TBI, despite potential negative impacts on gut health. ### Significance - **Clinical Significance**: This study provides new insights into the relationship between the gut microbiota and neuroinflammation post-TBI, laying the foundation for further exploration of potential therapeutic strategies. - **Future Directions**: Further research is needed to understand the specific mechanisms of broad-spectrum antibiotics on TBI recovery and how to balance their potential risks to gut health.

Antibiotic treatment induces microbiome dysbiosis and reduction of neuroinflammation following traumatic brain injury in mice.

An Integrated Analysis of Gut Microbiota and the Brain Transcriptome Reveals Host-Gut Microbiota Interactions Following Traumatic Brain Injury.

A Retrospective Clinical Analysis of the Serum Bile Acid Alteration Caused by Traumatic Brain Injury

Probiotic therapy modulates the brain-gut-liver microbiota axis in a mouse model of traumatic brain injury

Altered gut microbiota composition with antibiotic treatment impairs functional recovery after traumatic peripheral nerve crush injury in mice: effects of probiotics with butyrate producing bacteria

Traumatic Brain Injury–Induced Inflammation And Gastrointestinal Motility Dysfunction

Sustained Dysbiosis and Decreased Fecal Short-Chain Fatty Acids after Traumatic Brain Injury and Impact on Neurologic Outcome

Fecal Microbiota Transfer Attenuates Gut Dysbiosis and Functional Deficits After Traumatic Brain Injury

Moderate Traumatic Brain Injury Alters the Gastrointestinal Microbiome in a Time-Dependent Manner

Acute colitis during chronic experimental traumatic brain injury in mice induces dysautonomia and persistent extraintestinal, systemic, and CNS inflammation with exacerbated neurological deficits

Antibiotic-induced gut microbe dysbiosis alters neurobehavior in mice through modulation of BDNF and gut integrity

Investigating Alterations in Caecum Microbiota After Traumatic Brain Injury in Mice

Antibiotics impair and probiotics improve functional recovery after traumatic peripheral nerve crush injury in mice

Fecal microbiota transplantation inhibited neuroinflammation of traumatic brain injury in mice via regulating the gut–brain axis

Gut microbial regulation of innate and adaptive immunity after traumatic brain injury

Probiotic treatment causes sex-specific neuroprotection after traumatic brain injury in mice

Dysregulated brain-gut axis in the setting of traumatic brain injury: review of mechanisms and anti-inflammatory pharmacotherapies

Current state of neuroprotective therapy using antibiotics in human traumatic brain injury and animal models

Acute gastrointestinal permeability after traumatic brain injury in mice precedes a bloom in Akkermansia muciniphila supported by intestinal hypoxia

Long-term modification of gut microbiota by broad-spectrum antibiotics improves stroke outcome in rats

Fecal Microbiota Transplantation Is a Promising Method to Restore Gut Microbiota Dysbiosis and Relieve Neurological Deficits after Traumatic Brain Injury